nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density
|
Tapia, Edgar |
|
|
190 |
1 |
p. 69-78 |
artikel |
2 |
Breast cancer resistance mechanisms: challenges to immunotherapy
|
Hanna, Ann |
|
|
190 |
1 |
p. 5-17 |
artikel |
3 |
Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial
|
Ream, Molly E. |
|
|
190 |
1 |
p. 79-88 |
artikel |
4 |
Cardiac risk stratification of breast cancer patients in a cardio-oncology clinic
|
Doukas, Peter G. |
|
|
190 |
1 |
p. 133-142 |
artikel |
5 |
Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study
|
Moksud, Nafeesa |
|
|
190 |
1 |
p. 165-173 |
artikel |
6 |
Effects of exercise in breast cancer patients: implications of the trials within cohorts (TwiCs) design in the UMBRELLA Fit trial
|
Gal, Roxanne |
|
|
190 |
1 |
p. 89-101 |
artikel |
7 |
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)
|
Torrisi, Rosalba |
|
|
190 |
1 |
p. 103-109 |
artikel |
8 |
HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
|
de Moura Leite, Luciana |
|
|
190 |
1 |
p. 155-163 |
artikel |
9 |
Hormone receptor-positive breast cancer and black race: does sex matter?
|
Eskander, Mariam F. |
|
|
190 |
1 |
p. 111-119 |
artikel |
10 |
In regard to Van den Bruele AB et al. Management of ipsilateral breast tumor recurrence following breast conservation surgery: a comparative study of re-conservation vs mastectomy. Breast Cancer Res Treat. 2021 May;187(1):105–112. doi:10.1007/s10549-020-06080-9. Epub 2021 Jan 12. PMID: 33433775; PMCID: PMC8068641
|
Hannoun-Levi, Jean-Michel |
|
|
190 |
1 |
p. 3-4 |
artikel |
11 |
Investigating the role of endogenous estrogens, hormone replacement therapy, and blockade of estrogen receptor-α activity on breast metabolic signaling
|
Arnone, Alana A. |
|
|
190 |
1 |
p. 53-67 |
artikel |
12 |
Lazzaro responds to Pouwels et al.
|
Lazzaro, Carlo |
|
|
190 |
1 |
p. 1 |
artikel |
13 |
Multilevel predictors of guideline concordant needle biopsy use for non-metastatic breast cancer
|
Zgodic, Anja |
|
|
190 |
1 |
p. 143-153 |
artikel |
14 |
Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer
|
Sheean, Patricia |
|
|
190 |
1 |
p. 121-132 |
artikel |
15 |
The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS)
|
Al-Kawaz, Abdulbaqi |
|
|
190 |
1 |
p. 39-51 |
artikel |
16 |
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team
|
Jordan, V. Craig |
|
|
190 |
1 |
p. 19-38 |
artikel |